Dr. Md Nurunnabi is an Assistant Professor of Pharmaceutical Sciences in the School of Pharmacy and Adjunct faculty in Biomedical Engineering and Environmental Science & Engineering at the University of Texas at El Paso. Over the past decade, he received training in biomaterials, nanotechnology, and drug delivery. He received Bachelor in Pharmacy from UODA, and MS and PhD in Bioengineering and from the Korea National University of Transportation. Prior to starting his postdoctoral training at Harvard University in 2016, he has completed a short postdoctoral training at the Chungnam National University. In addition to his academic research, he has been involved in industrial research. He was co-founder and chief scientist at the KB BioMed Inc. (Currently Scientific Advisory Board), and an Associate Scientist in Chunbo Corporation Ltd, in South Korea. Dr. Nurunnabi has published over 50 peer-reviewed papers and edited two books and holds 10 issued/pending patents. Currently, he serves on the editorial advisory board of ACS Biomaterials Science & Engineering since and as Vice Chair of Controlled Release Society’s Bioinspired and Biomimetic Delivery focus group. He served as Secretary of Postdoc Association at Harvard Medical School (2016-2017) and President of Postdoc Association Massachusetts General Hospital (2017-2018) among various leadership roles. Dr. Jason R. McCarthy is an Assistant Professor in Radiology at Harvard Medical School and an Assistant in Chemistry at the Massachusetts General Hospital (MGH). In 2003, Dr. McCarthy received his Ph.D. in Inorganic Chemistry at the University of Connecticut under the tutelage of Dr. Christian Bruckner. Following graduate school, he joined the Center for Molecular Imaging Research (CMIR) at the MGH as an NIH Ruth L. Kirschstein National Research Service Award post-doctoral fellow, under the direction of Dr. Ralph Weissleder. In 2006, Dr. McCarthy was promoted to faculty at CMIR, subsequently joining CSB in 2009. The research being conducted by the McCarthy group at Centre for Systems Biology (CSB) is currently funded by several NIH grants and contracts, and is focused upon the synthesis and application of nanomaterials in the imaging and therapy of disease.